|
JBJS welcomes reader comments on published articles. Letters to the Editor are reviewed by JBJS editors but are not peer-reviewed. To submit your letter, please follow the "submit a response" link that appears in the content box at the upper right of the full text of the article.
Letters to the Editor to:
-
- Scientific Articles:
Javad Parvizi, Mark H. Ereth, and David G. Lewallen
- Thirty-Day Mortality Following Hip Arthroplasty for Acute Fracture
J Bone Joint Surg Am 2004; 86: 1983-1988
[Abstract]
[Full text]
[PDF]
|
|
Electronic letters published:
-
Thirty-day mortality following hip arthroplasty for acute fracture
- David G. Lewallen, Mark H. Ereth, M.D. and Javad Parvizi, M.D.
(12 October 2004)
-
Thirty-day mortality following hip arthroplasty for acute fracture.
- Christopher G. Moran, M.D., FRCS
(12 October 2004)
|
Thirty-day mortality following hip arthroplasty for acute fracture |
12 October 2004 |
|
|
David G. Lewallen, M.D. Mayo Clinic, Mark H. Ereth, M.D. and Javad Parvizi, M.D.
Send letter to journal:
Re: Thirty-day mortality following hip arthroplasty for acute fracture
lewallen.david{at}mayo.edu David G. Lewallen, et al.
|
September 24, 2004
Dear Professor Moran:
Thank you so much for your recent letter regarding our article from
the September issue of the journal on 30-day Mortality Following Hip
Arthroplasty For Acute Fracture. Beginning in 1969 with the first total
hip arthroplasty performed at our institution Dr. Mark Coventry then chair
of the Department of Orthopedic Surgery here at Mayo initiated a Total
Joint Registry. Since that time we have gathered in prospective fashion
information on all patients undergoing hip arthroplasty and subsequently
other total joint arthroplasties at the time of the index procedure and at
regular follow-up intervals subsequent to the operation. Details of this
more than three decade endeavor was recently documented in an article by
Berry et al. (Berry, D.J.; Kessler, M.; Morrey, B.F.: Maintaining a Hip
Registry for 25 Years. Mayo Clinic Experience. Clin Orthop Rel Res
344:61-68, Nov. 1997) As a result of these early and continuing efforts,
each and every patient is followed at 6 to 12 weeks following surgery,
again at one year, at 2 years and then at 5, 10 and 15 years post surgery
with follow-up continuing at five year increments thereafter. We now have
patients with greater than 30 years follow-up of procedures performed in
the early 1970’s. Each follow-up interval represents an opportunity to
track the patient and determine that death has occurred if in fact they
have died since an earlier contact or appointment. When patients found to
be lost to follow-up, extensive efforts are undertaken by our regular
staff who are employed full time in this endeavor to find them. If there
is no contact at their last known residence, then telephone contact is
made with country courthouses, and other public sources of information
regarding residences, and deaths in the area of the patient’s last known
address. Because of this effort we feel confident of the data regarding
mortality on our arthroplasty patients during the first 30 days post
surgery and indeed over the ensuing years post procedure.
The ability to generate reliable follow-up information from a large
single institutional data base, has helped serve as the basis for earlier
publications from our group on perioperative mortality in both hip and
knee arthroplasty populations compared to the demographic characteristics
in other areas. (Parvizi J, Johnson BG, Rowland C, Ereth MH, Lewallen DG.:
Thirty-day mortality after elective total hip arthroplasty. J Bone Joint
Surg Am. 2001 Oct;83-A(10):1524-8; Parvizi J, Sullivan TA, Trousdale RT,
Lewallen DG. : Thirty-day mortality after total knee arthroplasty. J Bone
Joint Surg Am. 2001 Aug;83-A(8):1157-61. )
In interpreting the data from our recent study of acute fracture
patients it is important to note that despite a significant referral
practice, a large portion of our patients, and especially those with
fractures, are drawn from the nearby upper mid west region. This area of
the United States has a low incidence of indigent patients and an under-
representation of minority populations when compared to the demographics
other areas of the United States and large urban centers both here and
abroad. These factors may result in a difference in observed mortality
over the first 30 days post hip arthroplasty for acute fracture when
compared to other institutions serving a very different patient
demographic.
The authors wish to thank Professor Moran for his interest and
questions as these have helped to bring out several important points of
potential interest to other readers.
Sincerely,
David G. Lewallen, M.D.
|
|
Thirty-day mortality following hip arthroplasty for acute fracture. |
12 October 2004 |
|
|
Christopher G. Moran, M.D., FRCS, Consultant Trauma & Orthopaedic Surgeon Queen's Medical Centre, University Hospital NHS Trust, Nottingham, NG7 2UH, UK
Send letter to journal:
Re: Thirty-day mortality following hip arthroplasty for acute fracture.
anne.hay{at}mail.qmcuh-tr.trent.nhs.uk Christopher G. Moran, M.D., FRCS
|
Dear Sir
Thirty-day mortality following hip arthroplasty for acute fracture.
I read with great interest this article by Drs Parvizi, Ereth and
Lewallen (JBJS 86-A; 1983-1987: September 2004). I should be grateful for
some more detail on the calculation of thirty-day mortality.
Thirty-day mortality should only be calculated when the outcome (i.e.
dead or alive) of the entire cohort or population is known thirty-days
after the index event. Complete follow-up of the entire cohort is required
for this calculation. A thirty-day mortality of 2.4% is remarkably low for
the elderly, hip fracture population, particularly as the background
mortality (death by natural causes) is 0.8% per month. Are the authors
calculating in-hospital mortality, rather than true thirty-day mortality?
This is an important issue if mortality rates are to be compared between
institutions as the low mortality rate quoted could be due to a relatively
short hospital stay with early rehabilitation in the community. Reductions
in length of stay may also explain the decrease in mortality over the past
three decades.
Yours sincerely
Prof. Christopher G Moran MD FRCS
Consultant Trauma & Orthopaedic Surgeon
|
|